Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

Market Cap	2.95B +45.3%
Revenue (ttm)	339.54M -2.7%
Net Income	16.49M +26.3%
EPS	0.14 +16.7%
Shares Out	121.20M
PE Ratio	173.86
Forward PE	n/a
Dividend	0.03 (0.12%)
Ex-Dividend Date	May 6, 2026

Volume	2,506,563
Average Volume	2,553,784
Open	24.69
Previous Close	24.34
Day's Range	23.29 - 24.69
52-Week Range	18.41 - 42.25
Beta	0.93
RSI	32.71
Earnings Date	Apr 30, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. It also provides pharma processing, such as pharma isolators, high-precision filling and dispensing, sterile transfer; cell and gene therap...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 790
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300813

Financial Performance

In 2025, SHE:300813's revenue was 339.54 million, a decrease of -2.71% compared to the previous year's 349.00 million. Earnings were 16.49 million, an increase of 26.32%.